Abstract
The purpose of this study was to compare the prostate-specific antigen (PSA) response to either neoadjuvant bicalutamide (BC) monotherapy or neoadjuvant luteinizing hormone-releasing hormone agonist (LHRHa) monotherapy and the subsequent effect on biochemical failure-free survival (BFFS) in men receiving radical radiotherapy (RT) for localized prostate cancer.
Original language | English |
---|---|
Pages (from-to) | 190-5 |
Number of pages | 6 |
Journal | Clinical genitourinary cancer |
Volume | 10 |
Issue number | 3 |
DOIs | |
Publication status | Published - Sept 2012 |
ASJC Scopus subject areas
- Oncology
- Urology